Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.22
+0.0900 (+7.96%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $1.74 Thursday, 9th May 2024 FGEN stock ended at $1.22. This is 7.96% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 20.73% from a day low at $1.06 to a day high of $1.28.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Dec 15, 2022 $14.68 $14.79 $14.20 $14.52 995 442
Dec 14, 2022 $15.06 $15.59 $14.92 $15.07 829 626
Dec 13, 2022 $14.66 $15.31 $14.22 $15.16 710 733
Dec 12, 2022 $14.50 $14.60 $13.99 $14.36 902 716
Dec 09, 2022 $14.90 $15.06 $14.07 $14.60 778 490
Dec 08, 2022 $15.47 $15.54 $14.38 $15.05 956 760
Dec 07, 2022 $15.79 $15.83 $15.17 $15.43 641 029
Dec 06, 2022 $16.04 $16.25 $15.67 $15.79 484 561
Dec 05, 2022 $16.49 $16.89 $15.94 $16.19 556 747
Dec 02, 2022 $14.76 $16.56 $14.10 $16.48 952 895
Dec 01, 2022 $14.43 $15.14 $14.26 $15.04 635 251
Nov 30, 2022 $14.37 $14.75 $13.95 $14.37 1 088 045
Nov 29, 2022 $14.08 $14.40 $13.86 $14.25 1 431 430
Nov 28, 2022 $13.81 $14.28 $13.77 $14.05 1 072 016
Nov 25, 2022 $13.86 $14.03 $13.55 $13.85 280 678
Nov 23, 2022 $13.78 $14.19 $13.71 $13.98 396 890
Nov 22, 2022 $13.89 $13.95 $13.53 $13.78 412 839
Nov 21, 2022 $14.44 $14.54 $13.72 $13.89 273 677
Nov 18, 2022 $15.24 $15.25 $14.59 $14.61 207 454
Nov 17, 2022 $14.83 $15.19 $14.69 $14.83 142 218
Nov 16, 2022 $14.83 $15.11 $14.61 $14.66 167 382
Nov 15, 2022 $15.34 $15.56 $14.75 $14.90 236 196
Nov 14, 2022 $15.41 $15.47 $14.71 $15.28 217 341
Nov 11, 2022 $16.04 $16.32 $15.47 $15.68 275 785
Nov 10, 2022 $15.66 $16.30 $15.28 $16.16 790 734
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT